Phibro Animal Health | Ativo Circulante





Ativo Circulante Alterar Data
Align Technology USD 2.62B 82.47M 2025-12
ANI Pharmaceuticals USD 698.4M 95.77M 2025-09
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 423.84M 41.46M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 445.82M 142.46M 2025-09
Corcept Therapeutics USD 541.13M 98.02M 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Henry Schein USD 4.4B 152M 2025-09
Idexx Laboratories USD 1.41B 63.23M 2025-12
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Pacira USD 562.75M 182.86M 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Supernus Pharmaceuticals USD 593.89M 144.98M 2025-09
Zoetis USD 6.77B 185M 2025-12


Phibro Animal Health Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.